Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
J AOAC Int. 2013 Jan-Feb;96(1):37-41.

Development and validation of a stability-indicating liquid chromatography method for the determination of dabigatran etexilate in capsules.

Author information

  • 1Federal University of Rio Grande do Sul, Faculty of Pharmacy, Postgraduate Program in Pharmaceutical Sciences, 90610-000 Porto Alegre-RS, Brazil. raquel.bernardi@yahoo.com.br


An RP-LC method was developed and validated for the determination of dabigatran etexilate in a capsule formulation. The LC method was carried out on a Zorbax C18 column (250 x 4.6 mm id). The mobile phase consisted of acetonitrile and a solution of triethylamine 0.1%, pH 6.0 adjusted with phosphoric acid (65 + 35, v/v) at a flow rate of 1.0 mL/min. The diode array detector was set at 225 nm. The chromatographic separation was obtained with retention time of 6.31 min, and linearity was in the range of 10-70 microg/mL (R2 = 0.9991). The specificity and stability-indicating capability of the method was proven through degradation studies and showing that there was no interference from the excipients. The accuracy was 100.23%, with an RSD of 1.34%. The LOD and LOQ were 0.04 and 10 microg/mL, respectively. Moreover, method validation demonstrated acceptable results for robustness and a system suitability test. The proposed method was applied for the analysis of the capsules to ensure their therapeutic efficacy.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Icon for Ingenta plc
    Loading ...
    Write to the Help Desk